FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 for a previous inspection.
483 Amgen Nov 2017

483 Amgen Nov 2017

$119 - Not in Stock

FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued inspectional observations (via FDA 483) on 03 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Nov 2017
  • Location: Thousand Oaks, United States
  • FEI: 2026154
Order